To investigate the mechanisms by which O-linked ␤-Nacetylglucosamine modification of nucleocytoplasmic proteins (O-GlcNAc) confers stress tolerance to multiple forms of cellular injury, we explored the role(s) of O-GlcNAc in the regulation of heat shock protein (HSP) expression. Using a cell line in which deletion of the O-GlcNAc transferase (OGT; the enzyme that adds O-GlcNAc) can be induced by 4-hydroxytamoxifen, we screened the expression of 84 HSPs using quantitative reverse transcriptase PCR. In OGT null cells the stressinduced expression of 18 molecular chaperones, including HSP72, were reduced. GSK-3␤ promotes apoptosis through numerous pathways, including phosphorylation of heat shock factor 1 (HSF1) at Ser 303 (Ser(P) 303 HSF1), which inactivates HSF1 and inhibits HSP expression. In OGT null cells we observed increased Ser(P) 303 HSF1; conversely, in cells in which O-GlcNAc levels had been elevated, reduced Ser(P) 303 HSF1 was detected. These data, combined with those showing that inhibition of GSK-3␤ in OGT null cells recovers HSP72 expression, suggests that O-GlcNAc regulates the activity of GSK-3␤. In OGT null cells, stress-induced inactivation of GSK-3␤ by phosphorylation at Ser 9 was ablated providing a molecular basis for these findings. Together, these data suggest that stress-induced GlcNAcylation increases HSP expression through inhibition of GSK-3␤.
(EC 2.4.1.-) (8, 9 ) and a neutral O-GlcNAc-specific hexosaminidase (O-GlcNAcase; EC 3.2.1.52) (10 -13), respectively. Like the O-GlcNAc modification, these enzymes are also localized to the mitochondria (4, 5, 14) , nucleus, and cytoplasm. Deletion of OGT is lethal in animals, tissues, and single cells, highlighting the key role of O-GlcNAc in regulating cellular function (15, 16) .
O-GlcNAc is thought to regulate protein function in a manner analogous to protein phosphorylation (1, 3, 17) . One mechanism by which O-GlcNAc may mediate these activities is by altering the phosphorylation status of proteins (18 -21) . Notably, O-GlcNAc and O-phosphate have been mapped to the same Ser/Thr residue on key cellular proteins, such as c-Myc (22) and RNA polymerase II (23, 24) . Both OGT and O-GlcNAcase have been found in complexes with phosphatases and kinases, suggesting that the exchange between phosphorylation and GlcNAcylation is rapid and dynamic (21, (25) (26) (27) . Similar to phosphorylation, O-GlcNAc is dynamically added and removed in response to numerous extracellular signals, including: extracellular glucose concentration (28 -30) , cell cycle (31) , development (32, 33) , hormones such as insulin (34, 35) , phorbol esters (36) , and the focus of this study, cellular stress (37) .
In response to injury, cells remodel their metabolic and signaling pathways to promote survival, the so-called cellular stress response (38, 39) . GlcNAcylation of intracellular proteins appears to be one target of the cellular stress response (1, 17, 25, 37, 40 -55) . O-GlcNAc levels increase in a dose-dependent manner in response to numerous forms of cellular injury (37) , and decline in some cell models of apoptosis (48) . These data, combined with those demonstrating that elevating O-GlcNAc levels before (1, 40 -45, 47, 48, 50, 51, 54) , or immediately after (46) , cellular injury improves survival in numerous models (heat stress, oxidative stress, hypoxia, ischemia reperfusion injury, and trauma hemorrhage injury) has led to the conclusion that stress-induced GlcNAcylation is a novel regulator of the cellular stress response. Interest-ingly, in some models of cellular injury, for example, ischemia reperfusion injury and trauma hemorrhage, the levels of O-GlcNAc decrease (45, 47, 48, (57) (58) (59) . Here, it appears that simply blocking the decrease in O-GlcNAc levels is protective. It is unclear if cells/tissues that die during ischemia reperfusion injury and trauma hemorrhage are undergoing necrosis/ apoptosis for similar reasons as the OGT null (16) .
Modulating O-GlcNAc appears to impact several pathways in a manner consistent with increased survival. These include: 1) improving protein solubility in models of heat stress (25, 60) ; 2) capacitative calcium entry (41, 46, 61) ; 3) reducing calpain activation (46); 4) p38 MAP kinase phosphorylation (43, 47) ; 5) modulation of circulating IL-6 and TNF-␣ levels (57, 62); 6) maintenance of mitochondrial membrane potential (48); 7) BCL2 translocation (63) ; and finally 8) regulating the expression of HSP72 (37) .
HSP72 belongs to a large family of ATP-dependent molecular chaperones, expressed constitutively or inducibly in most subcellular compartments (38, 39, 64 -66) . HSPs act to prevent cell death via numerous mechanisms, including: 1) refolding proteins; 2) preventing protein aggregation; 3) altering transcription; and 4) inhibiting apoptotic signaling pathways (38, 39, 64 -66) . Of the nine HSP70s in mammalian cells, the predominant stress-induced nuclear and cytosolic HSP70 is the result of transcription from two genes: Hsp70.1a and Hsp70.1b (64) . The products of these genes are 98% identical and are often referred to collectively as HSP72, which also delineates them from other HSP70 family members (64) . HSP72 is a key regulator of cell survival and deletion of HSP72 genes renders cells sensitive to environmental and physiological stress (67) (68) (69) (70) .
HSP72 expression is predominantly regulated at the level of transcription, which is mediated by the transcription factor, heat shock factor 1 (HSF1) (71, 72) . HSF1 is regulated at numerous points; in unstressed cells HSF1 is maintained as an inert monomer in a complex with HSP90 and other proteins in the cytoplasm. Upon stress, HSF1 disassociates from the HSP90, exposing a trimerization and nuclear localization domain. Once in the nucleus, HSF1 can bind DNA but is not fully active until phosphorylated at over 10 sites (71, 72) . HSF1 is also negatively regulated by phosphorylation (72) (73) (74) (75) (76) and acetylation (77) . Phosphorylation by GSK-3␤ at Ser 303 maintains HSF1 in an inactive state in unstressed cells, and is involved in deactivation of HSF1 post-stress promoting reduced DNA binding, nuclear export, and cytoplasmic sequestration by 14-3-3⑀ (73) (74) (75) (76) . Recently, it has been reported that HSF1 is acetylated and that this appears to peak post-stress enhancing HSF1 deactivation (77) .
Previously, we have shown that O-GlcNAc appears to regulate the expression of HSP72 and HSP40 (37) . To confirm these data and to determine whether O-GlcNAc regulates the expression of other molecular chaperones we have performed an RT-PCR array directed against 84 molecular chaperones. We have shown that O-GlcNAc appears to regulate the expression of at least 18 chaperones, including HSP72. To determine the mechanism(s) by which this occurs we have focused on the mechanism by which O-GlcNAc regulates the expression of HSP72. Two other groups have suggested that O-GlcNAc regulates HSP72 expression by either: 1) stabilizing the housekeeping transcription factor Sp1 to elevated temperatures, thus leading to enhanced HSP72 expression (60); or 2) by modulating the localization of HSF1 (78) . However, in this study we present an alternative model in which O-GlcNAc regulates HSP expression by modulating the phosphorylation and inactivation of GSK-3␤. As GSK-3␤ promotes apoptosis through numerous pathways (79 -82) , these studies highlight additional pathways through which O-GlcNAc may regulate cell survival, implicating O-GlcNAc in diseases/conditions in which the activity of GSK-3␤ is misregulated, such as Alzheimer disease and numerous forms of cancer (79, 81, 83, 84) .
EXPERIMENTAL PROCEDURES
Reagents-Reagents were purchased from Sigma, unless otherwise noted. LiCl was used at 10 mM in 0. Stress Treatments-Cells 46 h post-plating, and ϳ38 h post-4HT, were stressed at 45°C for up to 1 h in a humidified water-jacketed CO 2 incubator and returned to 37°C for the indicated lengths of time. For cells treated Ϯ4HT, medium containing the drug was removed 14 h prior to the experiment, the cells were washed with phosphate-buffered saline, pH 7.4, (PBS; 137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 TM System (Stratagene, La Jolla, CA) according to the manufacturer's instructions (SABiosciences). Each time point was analyzed independently three times. Expression was normalized to three control genes: ␤-actin (ActB), ␤-glucuronidase (GusB), and hypoxanthine guanine phosphoribosyltransferase 1 (hrpt1). Heat shock protein ␣90 kDa (cytosolic) and glyceraldehyde-3-phosphate dehydrogenase were also supplied as controls, but we observed stress-induced changes in expression of these proteins (supplemental Table S2 ) and as a result these transcripts were excluded as controls.
Protein Expression-Cells were washed with ice-cold PBS, harvested, and stored at Ϫ80°C. Total protein was extracted with sonication (5S, Setting 3, Fisher 550 Sonic dismembrator) in extraction buffer (1% (v/v) Nonidet P-40 in TBS (50 mM Tris-HCl, pH 7.5, 150 mM NaCl) with 0.5 mM PMSF, PIC1, PIC2, 2 M O-(2-acetamido-2-deoxy-D-glucopyranosylidene)-amino N-phenylcarbamate, 5 mM KF, and 5 mM ␤-glycerophosphate). Cellular debris were pelleted at 18,000 ϫ g (30 min at 4°C). Protein concentration was estimated using Coomassie Plus Protein Assay Reagent (Pierce Biotechnology). Equal protein (typically between 20 and 30 g) was separated on either Bio-Rad Tris Glycine SDS-PAGE gels (7.5 or 4 -15%; Criterion, Bio-Rad) or Invitrogen BisTris SDS-PAGE gels (8 or 4 -12%). Proteins were transferred to nitrocellulose or PVDF and blocked in either 3% (w/v) milk in TBST or 3% (w/v) BSA in TBST. HRP was detected using Immobilon Western Chemiluminescent substrate (Millipore Corporation, Billerica, MA) and detected on ECL-Hyperfilm (GE Healthcare).
Nuclear and Cytoplasmic Extracts-Cells were washed with ice-cold PBS, harvested, snap frozen, and stored at Ϫ80°C until required. Nuclear and cytoplasmic extracts were performed as previously reported by Qing and co-workers (85) in the presence of protease, phosphatase, and O-GlcNAcase inhibitors.
Densitometry-Densitometry was performed using nonsaturated chemiluminescent-exposed films and quantitated using a MacBAS bio-imaging analyzer (version 2.5, Fuji Photo Film Co.). Typically, multiple exposures from the same experiment were used to confirm that the signal was within the linear range. Levels of HSF1, Actin, or Ser(P) 303 HSF1 were normalized to that in OGT wild-type unstressed cells. In all instances, data are averaged from independent experiments (n Ͼ 3). Statistics are the result of a Student's t test or a twoway analysis of variance as indicated.
Immunoprecipitation-OGT wild-type and null cells were treated with heat shock (45°C) for either 20 or 40 min, or with the protein phosphatase inhibitor calyculin A (100 nM, 30 min). Cells were extracted with sonication (5S, Setting 3, Fisher 550 Sonic dismembrator) in buffer (20 mM HEPES, 150 mM NaCl, 1 mM EDTA, 0.5% (v/v) Nonidet P-40, pH 7.5) in the presence of protease, phosphatase, and O-GlcNAcase inhibitors. Cellular debris was pelleted by centrifugation at 18,000 ϫ g (30 min at 4°C). Extracts (2.5 mg) were immunoprecipitated with anti-HSF1 antibody (Assay Designs; 10 g) or control rabbit immunoglobulin (Santa Cruz Biotechnology; 10 g); which were covalently coupled to tosyl-activated Dynabeads (Invitrogen) according to the manufacturer's instructions. Extracts were incubated with beads overnight at 4°C, with rotation, washed 4 times in extraction buffer, and resuspended in SDS-PAGE sample buffer. Immunoprecipitates were separated on 8% BisTris gels and O-GlcNAc, HSF1, Ser(P) 303 HSF1, and actin were detected by immunoblot.
RESULTS

Generation of an Inducible OGT Knock-out Cell Line-Previously, we have shown that O-GlcNAc levels can be reduced by overexpression of Cre-recombinase in MEFs carrying an
Ogt exon flanked by loxP recombination sites (MEFs (OGT F/ Y)). Activation of these recombination sites deletes amino acids 206 -232, the consequent addition of 27 amino acids and a new translational termination site, effectively deleting OGT. Overexpression of Cre-recombinase using retrovirus results in OGT null cells ϳ5-7 days after the initial infection (16, 37) . This is an effective method for reducing OGT levels, but is plagued by three issues: 1) viral infection can stimulate stress response pathways (86); 2) the efficiency and timing of the knockout varies; and 3) retrovirus only infects dividing cells. To overcome these issues, we have stably transfected MEFs (OGT ); data not shown). The mER-Cre-2A-GFP plasmid contains a 2A sequence between the mER-Cre and GFP, and as a result, whereas one mRNA is transcribed, two proteins are translated: mER-Cre and GFP (87) (Fig. 1A) . mER-Cre encodes a mER fusion protein that has a higher affinity for 4HT than estrogen (88) . In the absence of ligand, the mER-Cre chimera is retained in the cytoplasm. In the presence of ligand, the mER-Cre chimera can dimerize and translocate to the nucleus recombining the loxP sites, resulting in an Ogt null allele (Ogt is X-linked). As expected, treatment of the mER-Cre-GFP-2A-MEFs (OGT F/Y ) cells with 0.5 M 4HT results in reduced OGT protein expression at 24 h. A Ͼ80% loss of OGT and O-GlcNAc was not achieved until ϳ48 h (Fig. 1, B and C) . A small amount of OGT persists, which is either a result of inefficiency of the Cre-recombinase, or a small number of untrans-duced cells. Notably, O-GlcNAcase expression is also reduced in OGT null cells (Fig. 1, B and C, discussed below) .
Previously, we have reported that deletion of OGT in cell culture is lethal, occurring after 2 rounds of cell division and an apparent period of senescence (16) . Consistent with previous data, OGT null cells appear to grow normally for 48 h, cell growth then slows, and cell death ensues between days 4 and 5 (Fig. 1D) . Consistent with these data, 48 h after the addition of 4HT we do not observe an increase in LDH release from OGT null cells when compared with wild-type cells (supplemental Fig. S1A ). Moreover, OGT null cells do not have elevated levels of caspase-3 activity or demonstrate cleavage of either caspase-3 or poly(ADP-ribose) polymerase (supplemental Fig. S1 , B and C) 48 h post-4HT treatment. With the exception of experiments examining the kinetics of OGT deletion, all experiments using the mER-Cre-2A-GFPMEFs (OGT F/Y ) cells were initiated and completed before 48 h.
The Expression of Numerous Molecular Chaperones Is Regulated by O-GlcNAc-The expression of 84 molecular chaperones was assessed simultaneously by qRT-PCR using a RT 2 
Profiler
TM PCR array (SABiosciences) in OGT wild-type and null cells that had been stressed for varying lengths of time. Of the chaperones examined, the basal mRNA expression of 8 chaperones was affected more than 1.5-fold (Table 1 , supplemental Fig. S1, and Fig. 2) , and the stress-induced expression of 21 chaperones was affected, by deletion of OGT/O-GlcNAc ( Table 2 , supplemental Fig. S2, and Fig. 2 ). 18 molecular chaperones had a reduction in their mRNA expression (Tables 1  and 2, supplemental Tables S1 and S2 , and Fig. 2 ), whereas 3 chaperones had enhanced expression (Dnajc5g, Dnajc5B, and Dnajb8; Table 2 and supplemental Table S2 ). Notably, the basal expression of Dnajb8 also appears up-regulated, although the data are not statistically significant (Fig. 2 , green dot, and supplemental Table S1 ). Interestingly, only one chaperone whose expression is induced by stress was unaffected by deletion of OGT: Dnajb11 (Fig. 2) .
To confirm these data, we examined the expression of a subset of these molecular chaperones by immunoblot (Fig. 3) . The stress-induced expressions of HSP72 and HSP90␣ were reduced in OGT null cells. However, expression of the closely related chaperones GRP75 and HSC70 were not altered, suggesting that the effect of deleting OGT on the expression of HSP72 (and other chaperones) was specific rather than a global effect on transcription or translation. To ensure that the effect of HSP expression was due to OGT deletion, rather than treatment of cells with 4HT, we performed these experiments in the OGT f/y MEFs that were stably transduced with GFP. Treatment of cells with 4HT, in the presence of OGT, did not alter the expression of HSPs (supplemental Fig. S2) .
Interestingly, the expression of GRP78 was only affected at the protein level. As we only observe GRP78 protein levels at 8 h, it is unclear if this is as GRP78 expression is regulated through a different mechanism or alternatively the transcription of GRP78 is induced after our last time point (HS 60 min, recovery 30 min).
De Novo O-GlcNAcylation Is Required for HSP Expression-To determine whether stress-induced GlcNAcylation is required for HSP expression, we showed that incubating cells with GlcNAc-thiazaline at the onset of Cre-activation (addition of 4HT) could maintain O-GlcNAc levels for 24 h, but not 48 h (supplemental Fig.  S3 ). As such, we examined the expression of HSP72 in cells 30 h post-4HT, incubated with and without GlcNAc-thiazaline (20 M). We observed no augmentation of HSP72 expression in OGT null cells (Fig. 4) , suggesting that stress-induced O-GlcNAcylation is important for the induction of HSP72.
HSF1 Does Not Appear to be O-GlcNAc
Modified-HSF1 is regulated by its trimerization status, localization, and by both activating and inhibitory phosphorylation events (71, 72) . Deletion of OGT did not alter stress-induced hyper-phosphorylation of HSF1 (supplemental Fig. S4) .
Previously, it has been reported that glutamine acts to regulate the localization of HSF1 in an O-GlcNAc-dependent manner (78) . Unlike the study of Singleton and Wischmeyer (78) deletion of OGT did not appear to alter nuclear localization of HSF1 (supplemental Fig. S5) ; and glutamine was able to induce HSP70 in the OGT null (supplemental Fig. S6 ). Consistent with these observations, our data suggests that HSF1 is not directly GlcNAcylated in either the MEFs (supplemental Fig. S7A ) or COS-7 cells used in this study (supplemental Fig. S7B ) before or after heat stress. In addition to CTD110.6, we failed to detect O-GlcNAc on HSF1 with either RL2 or sWGA (data not shown). O-GlcNAc may regulate HSF1 although several mechanisms and this may be cell type dependent. Notably, Hatsell and colleagues (89) have previously shown that Plakoglobin is O-GlcNAc modified in some tissues, and not in others.
Phosphorylation of Ser
303
, an Inhibitory Phosphorylation Site of HSF1, Is Reduced in OGT Null Cells-HSF1 can be inhibited by phosphorylation at Ser 303 , which is catalyzed by GSK-3␤ (73, 74) . Consistent with this observation, in control cells we observe a decrease in Ser(P) 303 HSF1 from cells harvested during the heat stress, and Ser(P) 303 HSF1 increases again once cells are returned to 37°C (supplemental Fig. S7B ). In COS-7 cells treated with GlcNAc-thiazaline (elevates O-GlcNAc levels), we observe an enhanced rate of Ser(P) 303 FIGURE 3. Deletion of OGT abrogates the expression of HSP72, HSP90, and GRP78, but not the closely related chaperones GRP75 and HSC70. OGT wild-type and null cells (38 h post-OGT deletion) were heat stressed at 45°C for 60 min, and recovered at 37°C for 2, 4, or 8 h. Cells were harvested 41, 43, and 47 h post-OGT deletion. The expression of OGT, O-GlcNAc, and the HSPs HSP72, HSC70, GRP78, and GRP75 were assessed by immunoblot (IB) (n ϭ 5). Actin is shown as a loading control. dephosphorylation (Fig. 5A) . To confirm these data, HSF1 was immunoprecipitated from OGT wild-type and null cells. Notably, the Ser(P) 303 HSF1 antibody was raised against human HSF1 and recognizes mouse HSF1 poorly in total cell lysates, but does recognize mouse HSF1 in immunoprecipitates. We observed higher basal levels of Ser(P) 303 in OGT null cells; Ser(P) 303 HSF1 decreases initially (HS20) in response to stress and this is dulled in OGT null cells (Fig. 5b) . Consistent with these signals being dependent on phosphorylation, treatment of cells with Calyculin A (PI in figure) , a protein phosphatase 1 and 2 inhibitor, also elevated the Ser(P) 303 signal. To confirm this mild trend, we also overexpressed O-GlcNAcase in COS-7 cells and observed elevated levels of Ser(P) 303 phosphorylation on HSF1 (supplemental Fig. S8 ). As we are unable to detect O-GlcNAc on HSF1, it is unlikely these data result from direct competition of O-GlcNAc and O-phosphate for the Ser 303 hydroxyl group. As such, we examined the activation/inactivation of GSK-3␤ in response to heat stress.
Phosphorylation at Ser 9 of GSK-3␤ Is Mis-regulated in OGT Null Cells-We examined stress-induced phosphorylation at Ser 9 of GSK-3␤ in cytosolic and nuclear extracts of OGT wild-type and null cells. Phosphorylation and inhibition of GSK-3␤ in cytosolic extracts was unaffected by deletion of OGT. However, in nuclear extracts of OGT null cells where GSK-3␤ acts on HSF1, phosphorylation at Ser 9 was delayed ϳ50 min (Fig. 6) .
Numerous kinases are known to phosphorylate GSK-3␤ at Ser 9 , including AKT/PKB, ERK, MAPK, AMPK, and mTOR (79 -83, 90) . Of these, the PI 3-kinase-AKT/PKB signaling pathway appears to phosphorylate GSK-3␤ in models of heat stress (91) . Consistent with this observation, inhibition of PI 3-kinase blocks stress-induced phosphorylation of GSK-3␤ in the MEFs used in this study. Based on these data, and on published data showing a role for O-GlcNAc in regulating the PI 3-kinase-AKT/PKB signaling pathway (92-95), we explored a role for O-GlcNAc in mediating the stress-induced activation of AKT/PKB. We observed a mild defect in nuclear translocation of AKT/PKB (Fig. 6 and supplemental Fig. S9 ), which may result in the disruption of GSK-3␤ phosphorylation observed in OGT null cells.
Inhibition of GSK-3␤ in OGT Null Cells Recovers HSP72 Expression-Consistent with elevated GSK-3␤ activity in OGT null cells resulting in reduced HSP72 levels, inhibition of GSK-3␤ with either LiCl or AR-A014418 resulted in the recovery of HSP72 expression in the OGT knockout (Fig. 7) .
O-GlcNAcase Expression Is Reduced in OGT Null CellsPreviously, we and others have reported that modulating O-GlcNAc levels (pharmacologically or genetically) results in cells altering the expression of either OGT or O-GlcNAcase to return GlcNAcylation to baseline (31) . As shown in supplemental Fig. S3 , an increasing concentration of GlcNActhiazaline (raises O-GlcNAc levels) is accompanied by elevation of O-GlcNAcase expression. Interestingly, when GlcNAc-thiazaline-treated cells are heat stressed, and where GlcNAcylation should be elevated, the increase in O-GlcNAcase expression declines (Fig. 4) . These data are consistent with the idea that the "cell can sense its state and adjust GlcNAcylation appropriately." Based on these data, we examined the expression of O-GlcNAcase in OGT null cells. In response to 4HT treatment, the expression of O-GlcNAcase is reduced with similar kinetics to that of OGT (Fig. 1, B and C) , even though the genes encoding each enzyme reside on different chromosomes. Interestingly, if cells incubated with 4HT also receive GlcNAc-thiazaline (20 M), O-GlcNAc levels and O-GlcNAcase expression are rescued (supplemental Fig. S3 and Fig. 4) . Together, these data suggest that: 1) the reduction of O-GlcNAcase is not an off-target effect of 4HT; 2) the deletion of OGT does not compromise the O-GlcNAcase gene; and 3) that the cell senses declining GlcNAcylation, a result of reduced OGT expression, and lowers O-GlcNAcase expression in an attempt to correct O-GlcNAc levels. Recently, it was reported that OGT and O-GlcNAcase interact directly (27) . Raising O-GlcNAc levels with an inhibitor of O-GlcNAcase (GT; Fig. 4) stabilizes O-GlcNAcase expression in the absence of OGT, suggesting that the interaction between OGT and O-GlcNAcase is not necessary for this phenomenon.
DISCUSSION
In this paper we have investigated the mechanisms by which O-GlcNAc regulates the expression of HSPs, to gain insight into the role(s) of O-GlcNAc in mediating cell survival. To facilitate these studies, we have generated a novel cell line in which OGT deletion can be induced by the addition of 4HT.
Notably, the OGT knockout is essentially also an O-GlcNAcase null (Fig. 1) . These data suggest that conclusions drawn from OGT knockouts will be complicated, as the resulting phenotype may also be the result of reduced O-GlcNAcase expression. Interestingly, the cells appear to contain a mechanism by which they can match the cellular state to GlcNAcylation levels. This is evidenced by 1) the maintenance of O-GlcNAcase expression in OGT null cells treated GlcNAc-thiazaline; and 2) that O-GlcNAcase expression is reduced in GlcNAc-thiazaline-treated cells that have been heat stressed.
Using the inducible OGT null cell line, we have screened the expression of 84 molecular chaperones and have shown that 18 proteins belonging to the HSP72 superfamily have reduced mRNA expression in the absence of OGT/O-GlcNAcase/O-GlcNAc. These data confirm our previous studies showing that O-GlcNAc regulates the expression of HSP72 (37) , and implicates O-GlcNAc in the regulation of other key chaperones including: DNAJ, HSP90␣, Serpin H, HSP105, GRP78, and BAG3. Many of these proteins, if not all, have been shown to promote cell survival through numerous mechanisms in response to various forms of cellular injury.
Given the key role of HSF1 in transactivating these genes (96, 97), we explored a role for O-GlcNAc in the regulation of this transcription factor. We found little evidence of HSF1 being modified by O-GlcNAc, but we did observe elevated levels of Ser(P) 303 on HSF1 in OGT null cells. Phosphorylation at this site is catalyzed by GSK-3␤, and inhibits HSF1 by reducing DNA binding, increasing nuclear export, and elevating binding to 14-3-3⑀ (73) (74) (75) . Consistent with stressed OGT null cells having elevated GSK-3␤ activity, inhibition of GSK-3␤ recovered HSP72 expression. Underlying this observation, we observed reduced inhibition by phosphorylation at Ser 9 of GSK-3␤ in the nuclei of OGT null cells. These data have led to a model (Fig. 7C ) in which O-GlcNAc promotes phosphorylation and inhibition of GSK-3␤, leading to a release of the inhibition of HSF1 and enhanced HSP synthesis. Consistent with previously published studies, the AKT/ PKB-PI 3-kinase signaling pathway is required for stress-induced phosphorylation of GSK-3␤ at Ser 9 . We observed a small defect in the nuclear translocation AKT/PKB ( Fig. 6 and supplemental Fig. S9 ), which may result in reduction in GSK-3␤ inactivation. Other alternatives may include altered subnuclear localization of AKT/PKB and GSK-3␤, or differential association with scaffold proteins required for efficient phosphorylation of AKT/PKB substrates.
Glutamine, a key metabolite in the synthesis of UDP-GlcNAc, is also known to regulate the expression of HSP72 (78, 98 -103) . Previously, it was suggested that O-GlcNAcylation of HSF1, or a HSF1-binding protein, was one mechanism by which glutamine elicits an effect on HSP72 expression (78) . However, in the cells used in these studies we observed no evidence of the O-GlcNAc modification on HSF1 and no defect in glutamine-induced HSP70 expression.
We, and others, have shown that O-GlcNAc appears to be one target of the cellular stress response. In this paper we have reported that O-GlcNAc regulates the expression of numerous molecular chaperones, including HSP72. Our findings that O-GlcNAc regulates the stress-induced inactivation of GSK-3␤ may have far reaching implications in models such as ischemic reperfusion injury. In addition to reducing heat shock protein expression through inactivation of HSF1 (discussed in this study), GSK-3␤ promotes the intrinsic pathway of apoptosis through numerous mechanisms: 1) GSK-3␤ binds to and promotes the acetylation of p53, which in turn activates proapoptotic changes in gene expression (104) ; 2) phosphorylation of myeloid cell leukemia sequence-1 by GSK-3␤ induces ubiquitination and subsequent degradation of this anti-apoptotic BCL-2 protein; 3) GSK-3␤ phosphorylates and inactivates the translation initiation factor eIF2B; 4) GSK-3␤ phosphorylates Bax at Ser 163 , promoting mitochondiral localization; 5) GSK-3␤ is required for the stressinduced expression of BIM; and 6) GSK-3␤ promotes collapse of mitochondrial membrane potential through opening of the mitochondrial permeability transition pore (56, 79, 104 -107) . The latter appears to be regulated by a number of events including direct phosphorylation by GSK-3␤ of VDAC, BCL-2, and p53, as well as binding of phospho-GSK-3␤ (inactive) to the adenine nucleotide translocase, which suppresses association with cyclophilin D reducing the sensitivity of the mitochondrial permeability transition pore to Ca 2ϩ induced opening (105, 106) . Notably, elevating O-GlcNAc levels has been shown to reduce opening of the mitochondrial permeability transition pore and to promote the maintenance of mitochondrial membrane potential during ischemia reperfusion injury (48, 50, 53, 54) , as such the data presented in this study may provide molecular insight into the mechanisms underlying this phenomena. These data also suggest additional GSK-3␤-dependent mechanisms by which dynamic stress-induced changes in GlcNAcylation may regulate cellular survival in response to injury. Finally, as GSK-3␤ plays a key role regulating the pathogenesis of Alzheimer disease, cardiac hypertrophy, as well as of many types of cancer, these data may suggest a role for O-GlcNAc in the etiology of these diseases.
